BioCentury | Jul 2, 2012
Strategy

Revving the engine

...SAIC-Frederick Inc., the primary contractor to the National Cancer Institute . Former CEO of Structural GenomiX...
BioCentury | Jun 28, 2011
Company News

Biogen Idec names Harris SVP of translational medicine

...Science Applications International Corp. (NYSE:SAI). Harris also was formerly the CEO of cancer company Structural GenomiX...
BioCentury | Jan 31, 2011
Financial News

Computable Genomix completes venture financing

...Computable Genomix LLC , Memphis, Tenn. Business: Pharmacogenetics Date completed: 1/25/11 Type: Venture financing Raised: Not...
BioCentury | Mar 6, 2007
Financial News

Calistoga raises $21 million

...as president; Neill Giese, previously SVP of biological sciences and drug development at Structural GenomiX...
BioCentury | Nov 20, 2006
Company News

Inovio Biomedical, VGX deal

...VGX (formerly Viral Genomix Inc.) received a worldwide non-exclusive license to INO's DNA delivery technology for...
BioCentury | Nov 6, 2006
Regulation

HCV antivirals

...compound Ph II (C ) Schering-Plough SCH 503034 HCV NS3 protease inhibitor Ph II Viral Genomix...
BioCentury | Apr 10, 2006
Product Development

CF Foundation collaborations

...INS37217 Respiratory, a P2Y(2) receptor agonist, for CF 2001 Structural GenomiX (now SGX Pharmaceuticals) Structural GenomiX...
BioCentury | Feb 1, 2006
Financial News

SGX drops IPO price range again

...Phase II/III trial as a third-line treatment for acute myelogenous leukemia (AML). SGX (formerly Structural GenomiX...
BioCentury | Jan 30, 2006
Strategy

Serono chronicles

...to show efficacy in a Phase II trial in severe psoriatic arthritisU. 3/23/04 - Structural GenomiX...
BioCentury | Jan 26, 2006
Financial News

SGX amends IPO

...Phase II/III trial as a third-line treatment for acute myelogenous leukemia (AML). SGX (formerly Structural GenomiX...
Items per page:
1 - 10 of 107
BioCentury | Jul 2, 2012
Strategy

Revving the engine

...SAIC-Frederick Inc., the primary contractor to the National Cancer Institute . Former CEO of Structural GenomiX...
BioCentury | Jun 28, 2011
Company News

Biogen Idec names Harris SVP of translational medicine

...Science Applications International Corp. (NYSE:SAI). Harris also was formerly the CEO of cancer company Structural GenomiX...
BioCentury | Jan 31, 2011
Financial News

Computable Genomix completes venture financing

...Computable Genomix LLC , Memphis, Tenn. Business: Pharmacogenetics Date completed: 1/25/11 Type: Venture financing Raised: Not...
BioCentury | Mar 6, 2007
Financial News

Calistoga raises $21 million

...as president; Neill Giese, previously SVP of biological sciences and drug development at Structural GenomiX...
BioCentury | Nov 20, 2006
Company News

Inovio Biomedical, VGX deal

...VGX (formerly Viral Genomix Inc.) received a worldwide non-exclusive license to INO's DNA delivery technology for...
BioCentury | Nov 6, 2006
Regulation

HCV antivirals

...compound Ph II (C ) Schering-Plough SCH 503034 HCV NS3 protease inhibitor Ph II Viral Genomix...
BioCentury | Apr 10, 2006
Product Development

CF Foundation collaborations

...INS37217 Respiratory, a P2Y(2) receptor agonist, for CF 2001 Structural GenomiX (now SGX Pharmaceuticals) Structural GenomiX...
BioCentury | Feb 1, 2006
Financial News

SGX drops IPO price range again

...Phase II/III trial as a third-line treatment for acute myelogenous leukemia (AML). SGX (formerly Structural GenomiX...
BioCentury | Jan 30, 2006
Strategy

Serono chronicles

...to show efficacy in a Phase II trial in severe psoriatic arthritisU. 3/23/04 - Structural GenomiX...
BioCentury | Jan 26, 2006
Financial News

SGX amends IPO

...Phase II/III trial as a third-line treatment for acute myelogenous leukemia (AML). SGX (formerly Structural GenomiX...
Items per page:
1 - 10 of 107